A profile of gout patients in Sarawak

被引:2
|
作者
Teh, C. L. [1 ]
Cheong, Y. K. [1 ]
Ling, H. N. [1 ]
Chan, P. L. [1 ]
Chan, T. [2 ]
Ling, G. R. [1 ]
机构
[1] Jalan Hosp, Sarawak Gen Hosp, Dept Med, Rheumatol Unit, Sarawak 93450, Malaysia
[2] Univ Liverpool, Liverpool L69 3BX, Merseyside, England
关键词
Gout; Tophi; Hospitalizations; EPIDEMIOLOGY; POPULATION; PREVALENCE;
D O I
10.1007/s00296-011-2245-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We performed a prospective study of all patients diagnosed with gout and who received treatment in Sarawak General Hospital from 1 July 2010 to 31 December 2010. There was a total of 138 patients in our study of which 92 (66.7%) were from the indigenous populations. They have a mean age of 56.5 +/- A 12.5 years with a mean duration of illness of 11.6 +/- A 8.7 years. The mean lag time between symptom onset to the diagnosis of gout was 2.8 +/- A 4.8 years and a mean lag time to appropriate treatment of gout of 8.8 +/- A 8.4 years. Sixty-six (47.8%) patients have family history of gout. The common complications of gout in our patients were tophi (47.1%), joint deformities (39.1%), kidney stones (16.7%), and uric acid nephropathy (0.7%). Hospitalization occurred in 93 (67.4%) patients. Gout is a serious medical problem in our centre. Gout affects middle-aged men, especially the indigenous populations. Almost half of our patients have a family history of gout and have tophi formations. Our gout patients have a significant delay in diagnosis and appropriate treatment, thus contributing to more complications and hospitalizations in our centre. There is an urgent need to educate both patients and healthcare workers on gout and its treatment to reduce the burden of chronic gout in Sarawak.
引用
收藏
页码:1079 / 1082
页数:4
相关论文
共 50 条
  • [31] Lesinurad in hyperuricaemia of gout: a profile of its use in the EU
    Blair H.A.
    Deeks E.D.
    Drugs & Therapy Perspectives, 2018, 34 (12) : 560 - 566
  • [32] EXPRESSION PROFILE AND POTENTIAL FUNCTION OF CIRCRNAS IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM PATIENTS WITH PRIMARY GOUT
    Qing, Y. F.
    Dai, F.
    Zhang, Q. B.
    Tang, Y. P.
    Dong, Z. R.
    He, Y. X.
    Jiang, Y.
    Huang, Y. Q.
    Zheng, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1040 - 1040
  • [33] GOUT AND HYPERLIPIDAEMIA (STUDY 50 PATIENTS WITH GOUT AND 50 CONTROLS)
    RONDIER, J
    TRUFFERT, J
    LEGO, A
    BROUILHE.H
    SAPORTA, L
    GENNES, LJD
    DELBARRE, F
    EUROPEAN JOURNAL OF CLINICAL AND BIOLOGICAL RESEARCH, 1970, 15 (09): : 959 - +
  • [34] Sex Differences in the Clinical Profile Among Patients With Gout: Cross-sectional Analyses of an Observational Study
    te Kampe, Ritch
    Janssen, Matthijs
    van Durme, Caroline
    Jansen, Tim L.
    Boonen, Annelies
    JOURNAL OF RHEUMATOLOGY, 2021, 48 (02) : 286 - 292
  • [35] Performance Of Gout Impact Scale Of The Gout Assessment Questionnaire In a Longitudinal Observational Study Of Patients With Gout
    Khanna, Puja
    Aquino-Beaton, Cleopatra
    Singh, Jasvinder A.
    Duffy, Erin
    Elashoff, David
    Khanna, Dinesh
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S850 - S851
  • [36] Better outcomes for patients with gout
    Richard Day
    Amy Nguyen
    Garry Graham
    Eindra Aung
    Mathew Coleshill
    Sophie Stocker
    Inflammopharmacology, 2020, 28 : 1395 - 1400
  • [37] LEAN, DRY GOUT PATIENTS
    DARLINGTON, LG
    ANNALS OF THE RHEUMATIC DISEASES, 1983, 42 : 90 - 90
  • [38] Colchicine prescribing in patients with gout
    Dalbeth, Nicola
    Gow, Peter
    NEW ZEALAND MEDICAL JOURNAL, 2011, 124 (1339) : 107 - 108
  • [39] Treatment adherence in patients with gout
    Reach, Gerard
    JOINT BONE SPINE, 2011, 78 (05) : 456 - 459
  • [40] PRIMARY GOUT IN AGING PATIENTS
    CARCASSI, A
    BOSCHI, S
    DUBALDO, F
    CAMPAGNA, S
    PEDIATRIC RESEARCH, 1985, 19 (07) : 748 - 748